Thus, miR-146a overexpression, in sex-hormones treated melanoma cells, supports the oncogenic role of miR-146a in melanoma by downregulating RNase-L expression and by activating the growth-promoting kinases ERK1/2. The gene discussed is RNASEL; the disease is melanoma.